Stage III vs. stage IV lung cancer: "Crossing a Great Divide"

Lung Cancer

Volumn 67, Issue 1, 2010, Pages 1-3

  Marks, Lawrence B ^a   Saynak, Mert ^a,b   Christodouleas, John P ^c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b TRAKYA UNIVERSITY   (Turkey)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; DISEASE FREE SURVIVAL; EDITORIAL; ESOPHAGITIS; FATIGUE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG SURGERY; MEDICAL DECISION MAKING; METASTASIS POTENTIAL; PATIENT DECISION MAKING; PATIENT SELECTION; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME; TUMOR LOCALIZATION;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING;

EID: 71649085291     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2009.10.018     Document Type: Editorial

References (29)

1. Trovo M.G., Zanelli G.D., Minatel E., Franchin G., and Gobitti C. Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer. Int J Radiat Oncol Biol Phys 24 (1992) 573-574
2. Schaake-Koning C., van den Bogaert W., Dalesio O., Festen J., Hoogenhout J., van Houtte P., et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 326 (1992) 524-530
3. Jeremic B., Shibamoto Y., Acimovic L., and Milisavljevic S. Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study. J Clin Oncol 14 (1996) 1065-1070
4. Dillman R.O., Seagren S.L., Propert K.J., Guerra J., Eaton W.L., Perry M.C., et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 323 (1990) 940-945
5. Vokes E.E., Herndon II J.E., Crawford J., Leopold K.A., Perry M.C., Miller A.A., et al. Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431. J Clin Oncol 20 (2002) 4191-4198
6. Kelly K., Crowley J., Bunn Jr. P.A., Presant C.A., Grevstad P.K., Moinpour C.M., et al. Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: a Southwest Oncology Group trial. J Clin Oncol 19 (2001) 3210-3218
7. Fossella F., Pereira J.R., von Pawel J., Pluzanska A., Gorbounova V., Kaukel E., et al. Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group. J Clin Oncol 21 (2003) 3016-3024
8. Belani C.P., Lee J.S., Socinski M.A., Robert F., Waterhouse D., Rowland K., et al. Randomized phase III trial comparing cisplatin-etoposide to carboplatin-paclitaxel in advanced or metastatic non-small cell lung cancer. Ann Oncol 16 (2005) 1069-1075
9. Bonnette P., Puyo P., Gabriel C., Giudicelli R., Regnard J.F., Riquet M., et al. Surgical management of non-small cell lung cancer with synchronous brain metastases. Chest 119 (2001) 1469-1475
10. Billing P.S., Miller D.L., Allen M.S., Deschamps C., Trastek V.F., and Pairolero P.C. Surgical treatment of primary lung cancer with synchronous brain metastases. J Thorac Cardiovasc Surg 122 (2001) 548-553
11. Flannery T.W., Suntharalingam M., Regine W.F., Chin L.S., Krasna M.J., Shehata M.K., et al. Long-term survival in patients with synchronous, solitary brain metastasis from non-small-cell lung cancer treated with radiosurgery. Int J Radiat Oncol Biol Phys 72 (2008) 19-23
12. Raney B., Anderson J., Breneman J., Donaldson S.S., Huh W., Maurer H., et al. Results in patients with cranial parameningeal sarcoma and metastases (Stage 4) treated on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols II-IV, 1978-1997: report from the Children's Oncology Group. Pediatr Blood Cancer 51 (2008) 17-22
13. Jeremic B., Shibamoto Y., Nikolic N., Milicic B., Milisavljevic S., Dagovic A., et al. Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: a randomized study. J Clin Oncol 17 (1999) 2092-2099
14. Castleberry R.P., Kun L.E., Shuster J.J., Altshuler G., Smith I.E., Nitschke R., et al. Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma. J Clin Oncol 9 (1991) 789-795
15. Pole J.G., Casper J., Elfenbein G., Gee A., Gross S., Janssen W., et al. High-dose chemoradiotherapy supported by marrow infusions for advanced neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol 9 (1991) 152-158
16. Donaldson S.S., Torrey M., Link M.P., Glicksman A., Gilula L., Laurie F., et al. A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group. Int J Radiat Oncol Biol Phys 42 (1998) 125-135
17. Livingston R.B., Mira J.G., Chen T.T., McGavran M., Costanzi J.J., and Samson M. Combined modality treatment of extensive small cell lung cancer: a Southwest Oncology Group study. J Clin Oncol 2 (1984) 585-590
18. Livingston R.B., Schulman S., Mira J.G., Harker G., Vogel S., Coltman Jr. C.A., et al. Combined alkylators and multiple-site irradiation for extensive small cell lung cancer: a Southwest Oncology Group Study. Cancer Treat Rep 70 (1986) 1395-1401
19. Grills I.S., Kestin L.L., Goldstein N., Mitchell C., Martinez A., Ingold J., et al. Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes. Int J Radiat Oncol Biol Phys 56 (2003) 658-670
20. Miller T.P., Dahlberg S., Cassady J.R., Adelstein D.J., Spier C.M., Grogan T.M., et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. N Engl J Med 339 (1998) 21-26
21. Rutqvist L.E., Rose C., and Cavallin-Stahl E. A systematic overview of radiation therapy effects in breast cancer. Acta Oncol 42 (2003) 532-545
22. Horning S.J., Weller E., Kim K., Earle J.D., O'Connell M.J., Habermann T.M., et al. Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern Cooperative Oncology Group study 1484. J Clin Oncol 22 (2004) 3032-3038
23. Rusthoven K.E., Hammerman S.F., Kavanagh B.D., Birtwhistle M.J., Stares M., and Camidge D.R. Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis. Acta Oncol 48 (2009) 578-583
24. Coy P., Schaafsma J., and Schofield J.A. The cost-effectiveness and cost-utility of high-dose palliative radiotherapy for advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 48 (2000) 1025-1033
25. van den Hout W.B., Kramer G.W., Noordijk E.M., and Leer J.W. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer. J Natl Cancer Inst 98 (2006) 1786-1794
26. Senkus-Konefka E., Dziadziuszko R., Bednaruk-Mlynski E., Pliszka A., Kubrak J., Lewandowska A., et al. A prospective, randomised study to compare two palliative radiotherapy schedules for non-small-cell lung cancer (NSCLC). Br J Cancer 92 (2005) 1038-1045
27. Macbeth F.R., Bolger J.J., Hopwood P., Bleehen N.M., Cartmell J., Girling D.J., et al. Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Medical Research Council Lung Cancer Working Party. Clin Oncol (R Coll Radiol) 8 (1996) 167-175
28. Kramer G.W.P.M., Wanders S.L., Noordijk E.M., Vonk E.J.A., van Houwelingen H.C., van den Hout W.B., et al. Results of the Dutch National Study of the palliative effect of irradiation using two different treatment schemes for non-small-cell lung cancer. J Clin Oncol 23 (2005) 2962-2970
29. Fairchild A., Harris K., Barnes E., Wong R., Lutz S., Bezjak A., et al. Palliative thoracic radiotherapy for lung cancer: a systematic review. J Clin Oncol 26 (2008) 4001-4011